Delivery Order SPE2DR25D1104-SPE2DR26FK744
- Not listed
- The Defense Logistics Agency awarded a $3,556.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 14, 2025, with completion targeted for November 17, 2025. This is a non-set-aside award issued as a delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,930.75 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on December 8, 2025, with a completion date of December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under a non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical...
- The Defense Logistics Agency awarded a delivery order valued at $33,819.84 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,327.38 for NURTEC ODT 75 MG tablets (8-count) on December 17, 2025, with completion scheduled for December 18, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $16,328.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) with an ultimate completion date of November 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $22,466.32 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) with a firm fixed price structure. This non-competitive delivery order was awarded on December 18, 2025, with an ultimate completion date of December 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a small-value pharmaceutical transaction typical of the agency's...
- The Defense Logistics Agency awarded a delivery order valued at $13,188.00 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity of 8 units) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,622.44 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on October 28, 2025, with an ultimate completion date of October 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded a $35,040.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract, which carries no set-aside designation, indicates a competitively awarded transaction supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $79,603.07 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) with an ultimate completion date of December 23, 2025. This non-set-aside competitive award was issued on December 22, 2025, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK744Delivery Order
The Defense Logistics Agency awarded a $30,464.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 22, 2025, with an ultimate completion date of December 23, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive pharmaceutical distribution network. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive vehicle enables the contractor to supply a wide range of pharmaceutical products and medical supplies globally to support military healthcare programs, including medications serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The delivery order exemplifies the company's role as a primary pharmaceutical supplier within DLA's Medical Supply Chain and its demonstrated capability to fulfill competitive federal procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.5k | 12/21/25 |